OIRA Conclusion of EO 12866 Regulatory Review
| RIN: 0910-AG38 View EO 12866 Meetings | Received Date: 10/01/2013 |
| Title: "Tobacco Products" Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act | |
| Agency/Subagency: HHS / FDA | Stage: Proposed Rule |
| Concluded Action: Consistent with Change | Concluded Date: 04/24/2014 |
| Legal Deadline: None | Economically Significant: Yes |
| Publication Date: 04/25/2014 | Unfunded Mandates: Private Sector |
| Major: Yes | Related To Homeland Security: No |
| Regulatory Flexibility Analysis Required: Yes | Small Entities Affected: Businesses |
| Federalism Implications: Yes | Affordable Care Act [Pub. L. 111-148 & 111-152]: No |
| International Impacts: Yes | Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No |
| Pandemic Response: Uncollected | |
An official website of the United States government



